Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMIMA4V)

Drug Name
BPX-501 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute lymphoblastic leukaemia 2A85 Phase 1/2 [1]
Acute myeloid leukaemia 2A60 Phase 1/2 [1]
Hematopoietic stem cell transplantation QB63 Phase 1/2 [2]
Immunodeficiency 4A00-4A85 Phase 1/2 [3]
Osteoporosis FB83.0 Phase 1/2 [4]
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMIMA4V

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting T-cells (T-cells)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ATG-Fresenius S DM4VJ5Q Transplant rejection NE84 Phase 3 [5]
DiabeCell DMK6FYR Insulin-dependent diabetes 5A10 Phase 2 [6]
TVI-Kidney-1 DMGYSZ0 Renal cell carcinoma 2C90 Phase 2 [7]
Baltaleucel-T DM3WCL4 Diffuse large B-cell lymphoma 2A81 Phase 2 [2]
T2c-001 DM06GDC Congestive heart failure BD10 Phase 2 [6]
AX-024 DMRQ32K Multiple sclerosis 8A40 Phase 1 [8]
RTL-1000 DM1B4CQ Multiple sclerosis 8A40 Phase 1 [9]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
T-cells (T-cells) TTXQYT6 NOUNIPROTAC Immunomodulator [2]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 ClinicalTrials.gov (NCT01744223) Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant. U.S. National Institutes of Health.
5 Clinical pipeline report, company report or official report of Neovii Biotech.
6 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
7 Clinical pipeline report, company report or official report of TVAX Biomedical.
8 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
9 RTL THERAPY FOR MULTIPLE SCLEROSIS: A Phase I Clinical Study. J Neuroimmunol. 2011 February; 231(1-2): 7-14.